In experiments using mouse models, the combined therapy significantly reduced tumor growth, suggesting that targeting the cancer cells’ resistance mechanism could make existing chemotherapy more powerful.
The center is named in memory of Aryeh Natanel Kluger who was diagnosed in March 2022 with a rare brain cancer, Anaplastic Pleomorphic Xanthoastrocytoma.